Login to Your Account

PhRMA: More dialogue in Japan to balance innovation, drug pricing

By Kohei Kanayasu
Staff Writer

Wednesday, February 8, 2017

TOKYO – Japan's pharmaceutical industry is calling for a more collaborative relationship between government and industry in the face of uncertainties in the country and the possibility of more frequent reviews of drug prices.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription